Artificial intelligence predicts direct-acting antivirals failure among hepatitis C virus patients: A nationwide hepatitis C virus registry program

MLA

Ming-Ying Lu, et al. “Artificial Intelligence Predicts Direct-Acting Antivirals Failure among Hepatitis C Virus Patients: A Nationwide Hepatitis C Virus Registry Program.” Clinical and Molecular Hepatology, vol. 30, no. 1, Jan. 2024, pp. 64–79. EBSCOhost, https://doi.org/10.3350/cmh.2023.0287.

APA

Ming-Ying Lu, Chung-Feng Huang, Chao-Hung Hung, Chi‐Ming Tai, Lein-Ray Mo, Hsing-Tao Kuo, Kuo-Chih Tseng, Ching-Chu Lo, Ming-Jong Bair, Szu-Jen Wang, Jee-Fu Huang, Ming-Lun Yeh, Chun-Ting Chen, Ming-Chang Tsai, Chien-Wei Huang, Pei-Lun Lee, Tzeng-Hue Yang, Yi-Hsiang Huang, Lee-Won Chong, … Ming-Lung Yu. (2024). Artificial intelligence predicts direct-acting antivirals failure among hepatitis C virus patients: A nationwide hepatitis C virus registry program. Clinical and Molecular Hepatology, 30(1), 64–79. https://doi.org/10.3350/cmh.2023.0287

Chicago

Ming-Ying Lu, Chung-Feng Huang, Chao-Hung Hung, Chi‐Ming Tai, Lein-Ray Mo, Hsing-Tao Kuo, Kuo-Chih Tseng, et al. 2024. “Artificial Intelligence Predicts Direct-Acting Antivirals Failure among Hepatitis C Virus Patients: A Nationwide Hepatitis C Virus Registry Program.” Clinical and Molecular Hepatology 30 (1): 64–79. doi:10.3350/cmh.2023.0287.